Edinburgh Investment Trust plc (EDIN) Ordinary 25p Shares
Sell:744.00p
Buy:745.00p
0
Change:
11.00p
(1.49%)
11.00p
(1.49%)
FTSE 250:1.14%
Market closed |
Prices as at close on 22 November 2024
Prices delayed by at least 15 minutes
|
Switch to live prices
|
- Add to watchlist
- Create an alert
- This stock can be held in a
Sell:744.00p
Buy:745.00p
Change:
11.00p
(1.49%)
11.00p
(1.49%)
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
Market closed |
Prices as at close on 22 November 2024
Prices delayed by at least 15 minutes
|
Switch to live prices
|
Ex-dividend
Sell:744.00p
Buy:745.00p
Change:
11.00p
(1.49%)
11.00p
(1.49%)
Market closed |
Prices as at close on 22 November 2024
Prices delayed by at least 15 minutes
|
Switch to live prices
|
Ex-dividend
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.
HL comment
Objective
The Company aims to invest primarily in UK securities with the long-term objective of achieving an increase of the Net Asset Value per share in excess of the growth in the FTSE All-Share Index and growth in dividends per share in excess of the rate of UK inflation.
| Security | Weight |
|---|---|
| Shell plc Ordinary EUR0.07 | 7.26% |
| Unilever plc Ordinary 3.11p | 5.47% |
| Compass Group plc Ordinary 11.05p | 4.88% |
| Tesco plc Ordinary 6.333p | 4.24% |
| Dunelm Group Ordinary 1p | 3.98% |
| NatWest Group plc ORD GBP1.0769 | 3.78% |
| GSK plc ORD GBP0.3125 | 3.69% |
| Haleon plc ORD GBP0.01 | 3.59% |
| AstraZeneca plc Ordinary US$0.25 | 3.53% |
| Verisk Analytics Inc | 3.41% |
| Sector | Weight |
|---|---|
| Industrials | 20.21% |
| Consumer Cyclical | 15.60% |
| Financial Services | 14.14% |
| Healthcare | 12.44% |
| Consumer Defensive | 11.21% |
| Energy | 8.60% |
| Communication Services | 6.17% |
| Basic Materials | 2.69% |
| Utilities | 1.92% |
| Real Estate | 1.70% |
| Country | Weight |
|---|---|
| United Kingdom | 90.36% |
| United States | 4.29% |
| Finland | 1.11% |
Fee Structure
The management fee arrangements is 0.04000% on the first GBP500 million and 0.03875% on the remainder of the market capitalisation of the Companys ordinary shares at each month end and paid monthly in arrears equivalent to an annualised fee of 0.480% on the first GBP500m and 0.465% on the remainder.
Dividend Policy
The Company second objective is to grow the dividend in excess of inflation. In the short term, the Board has the ability to decide on the level of the dividend - by paying dividends out of revenue or capital reserves if appropriate. But in the medium term dividend progression is a function of the Company finances. Dividends are payable quarterly, on November, February, May and July of each year.
ASSET SPLIT
Trust Manager
Imran Sattar
Manager Bio
Imran Sattar is Portfolio Manager for the Edinburgh Investment Trust plc and the Fund Manager responsible for managing the Liontrust UK Equity and UK Focus funds. Imran joined Liontrust in April 2022 as part of the acquisition of Majedie Asset Management, where he had managed funds for four years, and is a member of the Liontrust Global Fundamental team. Before joining Majedie in 2018, Imran was a Managing Director and Fund Manager at Blackrock, where he managed UK equity funds with combined UK equity assets of over £2 billion. Imran joined Mercury Asset Management in 1997 (subsequently acquired by Merrill Lynch, now Blackrock). He holds a Bachelor of Sciences degree in Mathematics & Economics from the University of Warwick and is a CFA Charterholder.
Board Of Directors
Elisabeth StheemanChairman, Patrick Edwardson, Aidan Lisser, Steven Baldwin, Annabel Tagoe-Bannerman
Data policy - All information should be used for indicative purposes only. You should
independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete,
and accepts no responsibility for how it may be used.
Objective, holding data, trust manager and bio information, dividend policy, asset split and fee structure are provided by Morningstar.
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.